FDA Approves Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum

Press/Media

Period1 Jan 2024 → 5 Jan 2024

Media coverage

3

Media coverage

  • TitleFDA Approval of Topical Berdazimer Gel Announced for Molluscum Contagiosum; The FDA decision on berdazimer gel, 10.3%, represents the second approved treatment for the viral-borne skin disease.
    Media name/outletConsultant Live
    Country/TerritoryUnited States
    Date5/01/24
    PersonsMark Kaufmann
  • TitleFDA Approval of Topical Berdazimer Gel Announced for Molluscum Contagiosum
    Media name/outletHCP Live
    Country/TerritoryUnited States
    Date5/01/24
    PersonsMark Kaufmann
  • TitleFDA Approves Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum
    Media name/outletDermatology Times
    Country/TerritoryUnited States
    Date1/01/24
    PersonsMark Kaufmann